Labshake search
Citations for R&D Systems :
1451 - 1500 of 3920 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... and further supplemented with 5 ng ml -1 of FGF-2 (R&D Systems). Medium was changed twice a week ...
-
bioRxiv - Biophysics 2023Quote: ... containing N2 supplement and 20 ng ml−1 EGF (R&D Systems, MN, USA) at 37°C in a 5% oxygen incubator ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Cell Biology 2023Quote: ... 30 ng/ml macrophage colony stimulating factor (M-CSF; R&D Systems, Minnesota, USA) and 100 U/ml penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 20 ng/mL of recombinant mouse interleukin (IL)- 2 (R&D systems), 8% CTS Immune Cell Serum Replacement (Thermo Fisher) ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was switched to basal medium with 10 ng/mL BMP4 (R&D Systems), 10 ng/mL FGF10 (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 40 ng/mL of IFN-λ (R&D Systems 5259-IL, Minneapolis, MN). Stimulated cells were then incubated at 37°C for 72 hours and timepoint samples were collected for IFN-stimulated and mock wells at 0 ...
-
bioRxiv - Bioengineering 2023Quote: ... and transforming growth factor–β3 (10 ng/ml; 243-B3-200; R&D Systems). On day 1 of culture ...
-
bioRxiv - Molecular Biology 2024Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: ... 2 ng/mL glial cell-derived neurotrophic factor (GDNF, R&D Systems #212-GD), 500 µg/mL dibutyryl cAMP (Sigma #D0627) ...
-
bioRxiv - Pathology 2024Quote: ... and 30 ng/ml macrophage colony-stimulating factor (M-CSF) (R&D Systems, MN). After the removal of adherent cells ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5) 10 ng/ml TGFβ1 (766-MB-005, R&D systems, Minneapolis, MN, US), 6 ...
-
bioRxiv - Molecular Biology 2024Quote: ... with 10 ng/mL mouse stem cell factor (SCF) (R&D Systems, 455-MC), 10 ng/mL mouse granulocyte macrophage colony-stimulating factor (R&D Systems ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/mL mouse granulocyte macrophage colony-stimulating factor (R&D Systems, GM-CSF) (415-ML) ...
-
bioRxiv - Cancer Biology 2020Quote: ... and stained for intracellular markers Arginase-1 (R&D Systems, IC5868P) and iNOS (Thermo Fisher ...
-
bioRxiv - Pathology 2020Quote: ... An anti-TLR4 capture antibody (100 ng/well in carbonate-bicarbonate buffer; R&D Systems, Minneapolis, MN) with demonstrable specificity for TLR in vitro (see Western blot ...
-
bioRxiv - Physiology 2022Quote: ... and the other half with 100 ng/kg of purified SEMA3F protein (3237-S3, R&D Systems), thrice per week ...
-
bioRxiv - Microbiology 2021Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend)) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (both R&D Systems, Minneapolis, USA), and Type B CpG OND D-SL01 (InvivoGen ...
-
bioRxiv - Immunology 2021Quote: ... and soluble anti-CD28 (2μg/ml; clone 37.51; eBioscience) in the presence of mIL-1β (10 ng/ml; R&D Systems), mIL-23 (10ng/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... A feeding layer of 2 ml RPMI growth medium supplemented with 10 ng/ml PDGF-BB ligand (R&D Systems) and/or 0.01 uM siRNA (see below ...
-
bioRxiv - Immunology 2021Quote: ... 100 IU/ml recombinant human IL-2 (R&D Systems), and 50 μM beta-mercaptoethanol (Fisher) ...
-
bioRxiv - Neuroscience 2022Quote: ... NGF (50ng/mL, R&D Systems, Cat# 256-GF-100), LIF (10ng/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... 100 IU/ml recombinant human IL-15 (R&D Systems) and small molecule inhibitors 1 μM XL-413 and M-3814 (Selleck Chemicals) ...
-
bioRxiv - Bioengineering 2023Quote: ... 100 IU/ml recombinant human IL-15 (R&D Systems). NFκB-reporter Jurkat cell line expressing cyan fluorescent protein (CFP ...
-
bioRxiv - Bioengineering 2023Quote: ... 100 IU/ml recombinant human IL-15 (R&D Systems) and aCD3/aCD28 Expamers as previously described 27.
-
bioRxiv - Bioengineering 2023Quote: ... or 100 ug/mL NRP-1 Antibody (R&D Systems) every other day for 5 days.
-
bioRxiv - Microbiology 2022Quote: ... IL-4 (R&D Systems Cat#204-IL-050, 20ng/mL), αIgG (Agilent Cat#A042402-2) ...
-
bioRxiv - Microbiology 2020Quote: ... and 4,000 U/ml of rh IL-4 (R&D Systems) and cultured for 5 days ...
-
bioRxiv - Molecular Biology 2020Quote: ... Primary antibodies used were anti-IL6 (R&D Systems, 1:100; overnight 4°C), anti-nucleolin (Santa Cruz ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Microbiology 2021Quote: ... Memory CD4+ T-cells were infected with HIV-1 (50 ng HIV-p24/106 cells) and then cultured in the presence of IL-2 (5 ng/ml; R&D Systems, Minneapolis, MN, USA) for up to 9 days ...
-
bioRxiv - Microbiology 2022Quote: ... AF488 anti-SARS-CoV-2 Spike S1 Subunit (R&D Systems,Cat# FAB105403G), FITC anti-Influenza A NP (Thermofisher ...
-
bioRxiv - Genetics 2019Quote: ... counted and seeded at 5.5 × 106 cells per well in 6-well suspension plates in 5.5 ml hESC media supplemented with 10 ng /ml activin A (R&D Systems) and 10 ng/ ml heregulinB (Peprotech) ...
-
bioRxiv - Immunology 2021Quote: ... and 500 ng/ml soluble anti-CD28 and cultured in the absence (Th0) or presence of 2.5 ng/ml IL-12 (R&D Systems) (Th1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... into 40 ml of R10 media supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050). Cells were passaged twice per week and feeder cells were added in a 1:1 ratio after 7 days to maintain stimulation ...
-
bioRxiv - Immunology 2023Quote: ... PBMCs were cultured for 8 days and stimulated with 2.5 ng/mL crude peanut extract (Stallergenes Greer) with or without 50 ug/mL anti-human IL-4Ra (R&D Systems), as previously described (17).
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... with or without 1.25 µg/mL Scl-Ab or 500 ng/mL anti-M-CSF antibody (#AF416 from R&D Systems). After 8 days ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant rat fractalkine (200 ng/ml; R&D Systems, MN, USA, #537-FT-025/CF) or vehicle (PBS ...
-
bioRxiv - Molecular Biology 2021Quote: ... in the presence of IL-3 (1 ng/mL, R&D Systems, Minneapolis, MN, USA) at 37°C and 5% CO2 ...
-
bioRxiv - Neuroscience 2021Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). The MN culture medium was replaced every other day for 6 days and the MN cultures were characterized by immunocytochemistry as described below ...
-
bioRxiv - Neuroscience 2020Quote: ... OPCM: N2B27 (no Vitamin A) supplemented with 10 ng/ml rhIGF-1 (R&D Systems), 20 ng/ml rhFGF2 (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... or 50 ng/ml macrophage colony- stimulating factor (M-CSF; R&D Systems, Abingdon, UK), respectively ...
-
bioRxiv - Genomics 2020Quote: ... 20 mM HEPES) supplemented with 60 ng/mL recombinant mouse M-CSF (R&D systems). For analysis of proliferation ...
-
bioRxiv - Microbiology 2021Quote: ... cells were cultured with 50 ng/mL CSF-1 (216-MC-01M, R&D Systems) for 14 days (70–72).
-
bioRxiv - Microbiology 2021Quote: ... Replacement of CHIR99021 by 20 ng/mL FGF-2 (223-FB-500, R&D Systems), followed by maintenance in 15 ng/mL VEGF and 5 ng/mL FGF-2 induced differentiation into the hematopoietic lineage according to a modified protocol from Grigoriadis et al ...
-
bioRxiv - Neuroscience 2020Quote: ... with addition of pen/strep and growth factor bFGF 10 ng/ml (R&D Systems). Medium was changed every third day and cells were enzymatically passaged using Accutase (Gibco) ...
-
bioRxiv - Physiology 2020Quote: ... Cells were stimulated with 50 ng/mL recombinant rat EGF (R&D systems, Minneapolis, MN) for times indicated.
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...